Lower Risk of Adverse Birth Outcomes With Tenofovir-emtricitabine-efavirenz Lower Risk of Adverse Birth Outcomes With Tenofovir-emtricitabine-efavirenz
Exposure of infants, from conception, to the antiretroviral combination of tenofovir disoproxil fumarate, emtricitabine, and efavirenz (TFC-FTC-EFV) is associated with a lower risk of adverse birth outcomes, compared with exposure to other antiretroviral regimens, according to data from Botswana.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 8, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news
NY gay man was refused HIV drug 'because he has gay sex'
The man, who lives in New York, applied for Truvada's PrEP in July to protect himself from the life-threatening disease. But he received a denial letter from United, citing his sexuality as a reason. (Source: the Mail online | Health)
Source: the Mail online | Health - August 4, 2017 Category: Consumer Health News Source Type: news
Truvada, vaginal ring safe for HIV prevention in adolescents
New research has shown that the use of a monthly vaginal ring and a daily oral Truvada are safe and effective at preventing HIV in adolescent girls. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 25, 2017 Category: Consumer Health News Source Type: news
In adolescents, oral Truvada and vaginal ring for HIV prevention are safe, acceptable
NIH-funded clinical trials are first of their kind to include younger adolescent girls. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - July 25, 2017 Category: American Health Source Type: news
Janssen Receives Positive CHMP Opinion for SYMTUZA ™
The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV
- Proven efficacy and durability of darunavir combined with the improved renal laboratory and bone mineral density profile of emtricitabine/tenofovir alafenamide as compared to emtricitabine/tenofovir disoproxil fumarate into one single tablet (Source: Johnson and Johnson)
Source: Johnson and Johnson - July 21, 2017 Category: Pharmaceuticals Source Type: news
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for HIV Treatment
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun. 12, 2017-- Gilead Sciences, Inc. (NASDAQ: GILD) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for an investigational, once-daily single... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - June 12, 2017 Category: Drugs & Pharmacology Source Type: news
How approval of a low-price generic HIV prevention drug could hit Gilead
Foster City's Gilead Sciences won approval in 2012 of Truvada as the first drug to prevent the spread of the AIDS virus. What does it mean now that Teva Pharmaceutical Industries has won the OK to introduce a supposedly low-cost version of the drug? (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 10, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news
How approval of a low-price generic HIV prevention drug could hit Gilead
Foster City's Gilead Sciences won approval in 2012 of Truvada as the first drug to prevent the spread of the AIDS virus. What does it mean now that Teva Pharmaceutical Industries has won the OK to introduce a supposedly low-cost version of the drug? (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 9, 2017 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
FDA Approves First Generic Truvada in US FDA Approves First Generic Truvada in US
Generic versions of emtricitabine/tenofovir disoproxil, which can both treat and prevent HIV infections, are already available in other countries.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 9, 2017 Category: Consumer Health News Tags: HIV/AIDS News Alert Source Type: news
Health Highlights: June 9, 2017
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Generic Version of HIV Drug Truvada Approved by FDA
The first generic version of the HIV drug Truvada (emtricitabine and tenofovir disoproxil... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 9, 2017 Category: General Medicine Source Type: news
FDA Approves First Generic Truvada for HIV Infection and Pre-Exposure Prophylaxis (PrEP)
June 8, 2017 - The U.S. Food and Drug Administration has approved the first generic version of Truvada for the treatment of HIV-1, in combination with other antiretroviral agents, and for pre-exposure prophylaxis (PrEP) in combination with safer sex... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 8, 2017 Category: Pharmaceuticals Source Type: news
Gilead reports positive data from four Phase III combination trials for HIV-1
US-based biopharmaceutical firm Gilead Sciences has reported positive results from four Phase III clinical trials investigating the combination of bictegravir (BIC), emtricitabine (FTC) and tenofovir alafenamide (TAF) to treat patients with HIV-1. (Source: Drug Development Technology)
Source: Drug Development Technology - May 30, 2017 Category: Pharmaceuticals Source Type: news
A GOP Health Care Plan May Ruin Our Best Chance At Ending HIV And AIDS
Before the pharmacist retrieves my prescription, she leans in and whispers: “Just so you know, it’s $1,300.” This happens almost every time, so I already have at the ready my coupon card from the drug’s manufacturer.
The card provides me with $3,600 in co-pays, or about three months worth of medicine, but now I’ve run out. I’m only on the hook for $80, after which I’ll hit my $7,150 health insurance deductible for the year. Then, until January, each monthly prescription will be free for me. I swipe my credit card.
Between the manufacturer-provided discounts and my private health i...
Source: Healthy Living - The Huffington Post - May 16, 2017 Category: Consumer Health News Source Type: news
Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 8, 2017 Category: Drugs & Pharmacology Source Type: news
Atripla (Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 24, 2017 Category: Drugs & Pharmacology Source Type: news
